![Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study | Nature Medicine Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-022-02097-3/MediaObjects/41591_2022_2097_Fig1_HTML.png)
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study | Nature Medicine
![When encephalitogenic T cells collaborate with microglia in multiple sclerosis | Nature Reviews Neurology When encephalitogenic T cells collaborate with microglia in multiple sclerosis | Nature Reviews Neurology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41582-019-0253-6/MediaObjects/41582_2019_253_Fig1_HTML.png)
When encephalitogenic T cells collaborate with microglia in multiple sclerosis | Nature Reviews Neurology
![Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis | Nature Reviews Neurology Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis | Nature Reviews Neurology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41582-021-00581-x/MediaObjects/41582_2021_581_Fig3_HTML.png)
Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis | Nature Reviews Neurology
![Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis | Nature Reviews Neurology Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis | Nature Reviews Neurology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41582-021-00581-x/MediaObjects/41582_2021_581_Fig1_HTML.png)
Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis | Nature Reviews Neurology
![Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis | Nature Reviews Drug Discovery Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis | Nature Reviews Drug Discovery](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnrd3248/MediaObjects/41573_2010_Article_BFnrd3248_Fig1_HTML.jpg)
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis | Nature Reviews Drug Discovery
![Progressive multiple sclerosis: from pathophysiology to therapeutic strategies | Nature Reviews Drug Discovery Progressive multiple sclerosis: from pathophysiology to therapeutic strategies | Nature Reviews Drug Discovery](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41573-019-0035-2/MediaObjects/41573_2019_35_Fig1_HTML.png)
Progressive multiple sclerosis: from pathophysiology to therapeutic strategies | Nature Reviews Drug Discovery
![Progressive multiple sclerosis: from pathophysiology to therapeutic strategies | Nature Reviews Drug Discovery Progressive multiple sclerosis: from pathophysiology to therapeutic strategies | Nature Reviews Drug Discovery](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41573-019-0035-2/MediaObjects/41573_2019_35_Fig1_HTML.png)